Atlas Trials

Trial of Primary Prophylaxis With rhTPO Administered to Patients With High Risk Sarcoma Receiving Intensive Chemotherapy

Clinical trial NCT00283582 · COMPLETED

Trial details

NCT number
NCT00283582
Sponsor
M.D. Anderson Cancer Center
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Sarcoma
Start date
2001-06-01
Primary completion
2004-11-01
Enrollment
50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.